EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy

Felix Carl Saalfeld, Johanna Möller, Petros Christopoulos, Carina Wenzel, Anna Rasokat, Xuejun Alice Wang, Ioannis Vathiotis, David König, Oliver Illini, Christian Grohé, Marcel Wiesweg, Claas Wesseler und 21 weitere

European Journal of Cancer · 2024-12 · 213 · 115065

DOI: 10.1016/j.ejca.2024.115065 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024-12. Verfasst von Felix Carl Saalfeld und 32 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Ger…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, ErbB Receptors, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsErbB ReceptorsImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsMutationHumansFemaleMaleAgedMiddle AgedRetrospective StudiesIntracellular Signaling Peptides and ProteinsProtein Kinase InhibitorsMembrane ProteinsAdultAged, 80 and overCell Transformation, NeoplasticProgression-Free SurvivalTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

DLL3EGFR mutationImmune checkpoint inhibitorNon-small cell lung cancerSmall cell transformation

Substanzen

ErbB ReceptorsDLL3 protein, humanImmune Checkpoint InhibitorsEGFR protein, humanIntracellular Signaling Peptides and ProteinsProtein Kinase InhibitorsMembrane ProteinsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.
  • Clinic for Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany.
  • Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, Germany; National Network Gen…
  • National Center for Tumor Diseases, Dresden, Germany; Department for Pathology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany; National Network Genomic Medicine Lung Cancer (nNGM), Germany.
  • Lung Cancer Group Cologne, Department I for Internal Medicine and Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Ge…
  • Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Zitieren

APA

Saalfeld, F. C., Möller, J., Christopoulos, P., Wenzel, C., Rasokat, A., Wang, X. A., Vathiotis, I., König, D., Illini, O., Grohé, C., Wiesweg, M., Wesseler, C., Schubart, C., Pelusi, N., Rohde, G., Overbeck, T. R., Kirfel, J., Alt, J., Kauffmann-Guerrero, D., …, & Wermke, M. (2024). Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy. European Journal of Cancer, 213, 115065. https://doi.org/10.1016/j.ejca.2024.115065

Vancouver

Saalfeld FC, Möller J, Christopoulos P, Wenzel C, Rasokat A, Wang XA, et al. Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy. European Journal of Cancer. 2024;213:115065. doi:10.1016/j.ejca.2024.115065

BibTeX
@article{Saalfeld2024,
  author = {Saalfeld, Felix Carl and Möller, Johanna and Christopoulos, Petros and Wenzel, Carina and Rasokat, Anna and Wang, Xuejun Alice and Vathiotis, Ioannis and König, David and Illini, Oliver and Grohé, Christian and Wiesweg, Marcel and Wesseler, Claas and Schubart, Christoph and Pelusi, Natalie and Rohde, Gernot and Overbeck, Tobias R and Kirfel, Jutta and Alt, Jürgen and Kauffmann-Guerrero, Diego and Griesinger, Frank and Kulhavy, Jonas and Allgäuer, Michael and Klimova, Anna and Schütz, Maret and Aust, Daniela E and Hochmair, Maximilian J and Rothschild, Sacha I and Syrigos, Konstantinos N and Veluswamy, Rajwanth and Michels, Sebastian and Stenzinger, Albrecht and Jöhrens, Korinna and Wermke, Martin},
  title = {Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {213},
  pages = {115065},
  doi = {10.1016/j.ejca.2024.115065}
}
Kostenlos starten →